COVID-19 and return to campus information.
University of California, Riverside
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.
Content developed by School of Medicine for physicians and other health care professionals includes grand rounds and a journal club delivered virtually
The first class of fellows begins training in the Coachella Valley’s Betty Ford Center and Eisenhower Medical Center on July 1
Telehealth visits can be conducted on a cell phone, tablet, or pad device, allowing even individuals without a computer or internet to be seen by a UCR Health physician
UC Riverside-led open-label pilot study leads to a double-blind clinical trial to further test ecopipam’s efficacy and safety in adult patients who stutter